goserelin has been researched along with Flushing* in 1 studies
1 trial(s) available for goserelin and Flushing
Article | Year |
---|---|
Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment.
Hot flushes are the commonest symptom induced by gonadotropin-releasing hormone agonists (GnRHa). We performed an open observational trial to evaluate the efficacy of veralipride, an antidopaminergic drug, in reducing hot flushes in 25 premenopausal women treated with a GnRHa for endometriosis (8 subjects) or menorrhagia (17 subjects). The patients received goserelin depot for 6 months and veralipride was added for the third month. Hot flushes, severe in all women at 2 months, improved in both frequency and intensity in 92% of the subjects during veralipride administration. The benefit obtained persisted until the end of the GnRHa treatment. Topics: Adult; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Flushing; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menorrhagia; Middle Aged; Prolactin; Sulpiride | 1992 |